New England Securities’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$1K Hold
667
﹤0.01% 1623
2014
Q3
$0 Hold
667
﹤0.01% 1857
2014
Q2
$0 Hold
667
﹤0.01% 1947
2014
Q1
$0 Hold
667
﹤0.01% 1919
2013
Q4
$0 Hold
667
﹤0.01% 1824
2013
Q3
$1K Hold
667
﹤0.01% 1608
2013
Q2
$1K Buy
+667
New +$1.17K ﹤0.01% 1396

Other funds holding GCVRZ

New England Securities's GCVRZ Position: Q4 2014 in Review

New England Securities held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q4 2014 at 667 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

New England Securities first reported a position in GCVRZ in Q2 2013 and has held it in 7 quarters since. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2014.

  • New England Securities held 667 shares of Sanofi Contingent Value Rights worth $1K as of Q4 2014.
  • New England Securities left its Sanofi Contingent Value Rights share count unchanged in Q4 2014.
  • Sanofi Contingent Value Rights made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1623 holding.
  • New England Securities first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 7 quarters since.
  • 118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.